Sign in/Register
Blaauboer S, Gabrielle V, Jin L, MPYS/STING-mediated TNF-a, not type I IFN, is essential for the mucosal adjuvant activity of (3'-5')-cyclic-di-guanosine-monophosphate in vivo. J Immunol 192, 492-502, (2014). PMID: 24307739
Chen N et al., Tunable degradation of acetalated dextran microparticles enables controlled vaccine adjuvant and antigen delivery to modulate adaptive immune responses. J Control Release 273, 147-159, (2018).
Gallovic MD et al., Chemically modified inulin microparticles serving dual function as a protein antigen delivery vehicle and immunostimulatory adjuvant. Biomater Sci 4(3):483-93, (2016). PMID: 26753184
Korupalli C et al., Single-injecting, bioinspired nanocomposite hydrogel that can recruit host immune cells in situ to elicit potent and long-lasting humoral immune responses. Biomaterials 216, 119268, (2019).
Swaminathan G et al., A novel lipid nanoparticle adjuvant significantly enhances B cell and T cell responses to sub-unit vaccine antigens. Vaccine 34, 110-9, (2016). PMID: 26555351
Uchida S et al., Designing immunostimulatory double stranded messenger RNA with maintained translational activity through hybridization with poly A sequences for effective vaccination. Biomaterials 150:162-170, (2018). PMID: 29031816
Wang P et al., Phosphatase wild-type p53-induced phosphatase 1 controls the development of TH9 cells and allergic airway inflammation. J Allergy Clin Immunol 141(6):2168-2181, (2018). PMID: 28732646
Watanabe S, Inoue J, Intracellular delivery of lipopolysaccharide induces effective Th1-immune responses independent of IL-12. PLoS One 8, e68671, (2013). PMID: 23874715
Xu Y, Tang H, Liu J, Wang H, Liu Y, Evaluation of the adjuvant effect of silver nanoparticles both in vitro and in vivo. Toxicol Lett 219, 42-8, (2013). PMID: 23454833
Related
NEWS, ANNOUNCEMENTS, PROMOTIONS AND MORE